Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 895
Filtrer
1.
Int J Tuberc Lung Dis ; 22(12): 1505-1510, 2018 12 01.
Article de Anglais | MEDLINE | ID: mdl-30606324

RÉSUMÉ

SETTING: The number of patients with non-tuberculous mycobacterial lung disease (NTM-LD) worldwide has been increasing. Mycobacterium avium complex lung disease (MAC-LD) accounts for 90% of NTM-LD. MAC-LD necessitates long-term treatment, but adverse reactions with long-term administration of drugs are poorly understood. OBJECTIVE: To evaluate adverse reactions with long-term administration of drugs for MAC-LD. DESIGN: We conducted a retrospective single-centre medical chart review of 364 patients administered two or more drugs between July 2010 and June 2015. RESULTS: The prevalence and median time to onset of adverse reactions were as follows: hepatotoxicity 19.5%, 55 days; leucocytopaenia 20.0%, 41 days; thrombocytopaenia 28.6%, 61.5 days; cutaneous reactions 9.3%, 30 days; ocular toxicity 7.7%, 278 days; and increase in serum creatinine 12.4%, 430.5 days. Multivariate analysis showed that rifampicin use was independently associated with thrombocytopaenia, and ethambutol use was independently associated with increases in serum creatinine. CONCLUSION: The main adverse reactions appeared within 3 months after start of treatment. Most patients were able to continue treatment with liver-supporting therapy, antihistamine agents or desensitisation therapy; however, ocular toxicity must be monitored for up to 1 year after start of treatment.


Sujet(s)
Antibactériens/effets indésirables , Effets secondaires indésirables des médicaments/épidémiologie , Maladies pulmonaires/traitement médicamenteux , Infection due à Mycobacterium avium-intracellulare/traitement médicamenteux , Adolescent , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Antibactériens/administration et posologie , Calendrier d'administration des médicaments , Éthambutol/effets indésirables , Femelle , Humains , Japon/épidémiologie , Modèles logistiques , Mâle , Adulte d'âge moyen , Analyse multifactorielle , Complexe Mycobacterium avium , Études rétrospectives , Rifampicine/effets indésirables , Expectoration/microbiologie , Facteurs temps , Jeune adulte
2.
Oncogenesis ; 6(6): e350, 2017 Jun 26.
Article de Anglais | MEDLINE | ID: mdl-28650445

RÉSUMÉ

Here, by combining lipidomics with transcriptome analysis, we demonstrate that Rb depletion in mouse embryonic fibroblastss induces significant alterations in their lipid composition. We discovered that Rb depletion induced increase in lysophosphatidylserine, diacylglycerol (DAG), fatty acid (FA), acylcarnitine, phosphatidylcholine (PC), arachidonoyl ethanolamine, and decrease in phosphatidylglycerol, monoacylglycerol, without change in total lipid per protein levels. Analysis of the acyl chain composition of DAG, PC and phosphatidylserine revealed increase of saturated and mono-unsaturated acyl chains with specific carbon chain length. Consistently, we observed that Rb depletion increased the levels of fatty acids with the corresponding carbon chain length and number of carbon-carbon double bondssuch as myristic acid (14:0), palmitic acid (16:0), stearic acid (18:0) and all forms of FA 18:1. Microarray analysis revealed that Rb depletion induced significant upregulation of enzymes involved in elongation and desaturation of fatty acids. Among these, we found that elongation of long chain fatty acid family member 6 (Elovl6) and stearoyl-CoA desaturase 1 (Scd1) are the most robustly controlled by Rb possibly through E2F and sterol regulatory element-binding protein transcription factors. Depletion of Elovl6 or Scd1 significantly suppressed colony formation, sphere formation and xenograft tumor growth of Rb-deficient tumor cells. Suppression of self-renewal by the SCD1 inhibitor was rescued upon supplementation of the mono-unsaturated fatty acids generated by this enzyme. This study suggests a novel role for Rb in suppressing the malignant progression of tumors by controlling the lipid composition.

3.
Oncogene ; 36(36): 5145-5157, 2017 09 07.
Article de Anglais | MEDLINE | ID: mdl-28481867

RÉSUMÉ

Retinoblastoma (RB) protein inactivation during tumor progression is often associated with acquisition of immature phenotypes and resistance to therapy. Determination of an RB inactivation signature in a context of gaining undifferentiated phenotype in a p53-null sarcoma system revealed a critical role for interleukin (IL)-6. Using a Gene Set Enrichment Analysis (GSEA), we discovered that poorly differentiated breast cancers are enriched for this RB inactivation signature. Accelerated IL-6 secretion following RB inactivation in an RB-intact luminal-type breast cancer cell line MCF-7 promoted a positive feed forward loop between IL-6 and STAT3 driving tumor growth and endocrine therapy resistance. In addition, some of RB-intact basal-like type breast cancer cell lines exhibited a similar phenotype following RB depletion. The mechanism whereby RB inactivation increases IL-6 production in MCF-7 cells appeared to involve fatty acid oxidation (FAO)-dependent mitochondrial metabolism and c-Jun NH(2)-terminal kinase (JNK). In addition, IL-6, via STAT3-mediated feedback to mitochondria, autonomously adjusts mitochondrial superoxide to levels suitable to maintain stem cell-like activity. The gene expression profile of luminal-type breast cancer patients with low RB expression revealed high enrichment of genes involved in mitochondrial respiration and downstream targets of IL-6. These findings unveiled an unexpected strategy whereby RB suppresses malignant features of cancer cells through metabolic reprogramming and cell-autonomous inflammation.


Sujet(s)
Tumeurs du sein/anatomopathologie , Auto-renouvellement cellulaire/effets des médicaments et des substances chimiques , Résistance aux médicaments antinéoplasiques , Interleukine-6/métabolisme , Mitochondries/anatomopathologie , Protéine du rétinoblastome/métabolisme , Tamoxifène/pharmacologie , Animaux , Antinéoplasiques hormonaux/pharmacologie , Apoptose/effets des médicaments et des substances chimiques , Marqueurs biologiques tumoraux/génétique , Marqueurs biologiques tumoraux/métabolisme , Tumeurs du sein/traitement médicamenteux , Tumeurs du sein/métabolisme , Différenciation cellulaire/effets des médicaments et des substances chimiques , Prolifération cellulaire/effets des médicaments et des substances chimiques , Acides gras/composition chimique , Acides gras/métabolisme , Femelle , Humains , Interleukine-6/génétique , Métabolome , Souris , Souris de lignée C57BL , Souris knockout , Mitochondries/effets des médicaments et des substances chimiques , Mitochondries/métabolisme , Protéine du rétinoblastome/génétique , Facteur de transcription STAT-3/génétique , Facteur de transcription STAT-3/métabolisme , Cellules cancéreuses en culture , Protéine p53 suppresseur de tumeur/physiologie , Tests d'activité antitumorale sur modèle de xénogreffe
4.
Clin Microbiol Infect ; 20(11): O831-9, 2014 Nov.
Article de Anglais | MEDLINE | ID: mdl-24813594

RÉSUMÉ

The inoculum effect is a laboratory phenomenon in which the minimal inhibitory concentration (MIC) of an antibiotic is increased when a large number of organisms are exposed. Due to the emergence of extended-spectrum ß-lactamase-producing Klebsiella pneumoniae (ESBL-Kpn) infections, the inoculum effect of ESBL-Kpn on ß-lactams was studied in vitro and in vivo using an experimental model of pneumonia. The in vitro inoculum effect of 45 clinical ESBL-Kpn isolates on ß-lactams was evaluated at standard (10(5) CFU/mL) and high (10(7) CFU/mL) organism concentrations. The MIC50 of piperacillin-tazobactam, cefotaxime and cefepime was increased eight-fold or more and that of meropenem was increased two-fold. The in vivo inoculum effect was evaluated in an ESBL-Kpn pneumonia mouse model treated with bacteriostatic effect-adjusted doses of piperacillin-tazobactam (1000 mg/kg four times daily, %T>MIC; 32.60%) or meropenem (100 mg/kg twice daily, %T>MIC; 28.65%) at low/standard (10(4) CFU/mouse) and high (10(6) CFU/mouse) inocula. In mice administered a low inoculum, no mice died after treatment with piperacillin-tazobactam or meropenem, whereas all the control mice died. In contrast, in the high inoculum model, all mice in the piperacillin-tazobactam-treated group died, whereas all meropenem-treated mice survived and had a decreased bacterial load in the lungs and no invasion into the blood. In conclusion, meropenem was more resistant to the inoculum effect of ESBL-Kpn than piperacillin-tazobactam both in vitro and in vivo. In the management of severe pneumonia caused by ESBL-Kpn, carbapenems may be the drugs of choice to achieve a successful outcome.


Sujet(s)
Antibactériens/pharmacologie , Infections à Klebsiella/traitement médicamenteux , Klebsiella pneumoniae/effets des médicaments et des substances chimiques , Acide pénicillanique/analogues et dérivés , Thiénamycine/pharmacologie , Animaux , Antibactériens/usage thérapeutique , Charge bactérienne , Modèles animaux de maladie humaine , Poumon/microbiologie , Mâle , Méropénème , Souris de lignée BALB C , Tests de sensibilité microbienne , Acide pénicillanique/pharmacologie , Acide pénicillanique/usage thérapeutique , Pipéracilline/pharmacologie , Pipéracilline/usage thérapeutique , Association de pipéracilline et de tazobactam , Pneumopathie bactérienne/traitement médicamenteux , Analyse de survie , Thiénamycine/usage thérapeutique
5.
Eur J Clin Microbiol Infect Dis ; 32(3): 387-97, 2013 Mar.
Article de Anglais | MEDLINE | ID: mdl-23052987

RÉSUMÉ

The safety and efficacy profile of caspofungin and micafungin in Japanese patients with fungal infections were directly compared in this prospective, randomized, double-blind study. The proportion of patients who developed significant drug-related adverse event(s) (defined as a serious drug-related adverse event or a drug-related adverse event leading to study therapy discontinuation) was compared in 120 patients [caspofungin 50 mg, or 50 mg following a 70-mg loading dose on Day 1 (hereinafter, 70/50 mg) group: 60 patients; micafungin 150 mg: 60 patients]. The overall response rate was primarily evaluated in the per-protocol set (PPS) population. The proportion of patients who developed significant drug-related adverse events was 5.0 % (3/60) in the caspofungin group and 10.0 % (6/60) in the micafungin group [95 % confidence interval (CI) for the difference: -15.9 %, 5.2 %]. The favorable overall response in the PPS population for patients with esophageal candidiasis, invasive candidiasis, and chronic pulmonary aspergillosis including aspergilloma was 100.0 % (6/6), 100.0 % (3/3), and 46.7 % (14/30) in the caspofungin group, and 83.3 % (5/6), 100.0 % (1/1), and 42.4 % (14/33) in the micafungin group, respectively. In Japanese patients with Candida or Aspergillus infections, there was no statistical difference in the safety between caspofungin and micafungin. Consistent with other data on these two agents, the efficacy of caspofungin and micafungin was similar.


Sujet(s)
Aspergillose/traitement médicamenteux , Candidose/traitement médicamenteux , Échinocandines/administration et posologie , Échinocandines/effets indésirables , Lipopeptides/administration et posologie , Lipopeptides/effets indésirables , Sujet âgé , Sujet âgé de 80 ans ou plus , Antifongiques/administration et posologie , Antifongiques/effets indésirables , Caspofungine , Méthode en double aveugle , Effets secondaires indésirables des médicaments/épidémiologie , Effets secondaires indésirables des médicaments/anatomopathologie , Femelle , Humains , Japon , Mâle , Micafungine , Adulte d'âge moyen , Études prospectives , Résultat thérapeutique
6.
Eur Respir J ; 38(4): 861-9, 2011 Oct.
Article de Anglais | MEDLINE | ID: mdl-21828032

RÉSUMÉ

Several mutations in the surfactant protein C (SP-C) gene (SFTPC) have been reported as causing familial pulmonary fibrosis (FPF). However, the genetic background and clinical features of FPF are still not fully understood. We identified one Japanese kindred, in which at least six individuals over three generations were diagnosed with pulmonary fibrosis. We examined the patients radiologically and histopathologically and sequenced their SFTPC and ABCA3 genes. We also established a cell line stably expressing the mutant gene. All the patients had similar radiological and histopathological characteristics. Their histopathological pattern was that of usual interstitial pneumonia, showing numerous fibroblastic foci even in areas without abnormal radiological findings on chest high-resolution computed tomography. No child had respiratory symptoms in the kindred. Sequencing of SFTPC showed a novel heterozygous mutation, c.298G>A (G100S), in the BRICHOS domain of proSP-C, which co-segregated with the disease. However, in the ABCA3 gene, no mutation was found. In vitro expression of the mutant gene revealed that several endoplasmic reticulum stress-related proteins were strongly expressed. The mutation increases endoplasmic reticulum stress and induces apoptotic cell death compared with wild-type SP-C in alveolar type II cells, supporting the significance of this mutation in the pathogenesis of pulmonary fibrosis.


Sujet(s)
Asiatiques/génétique , Stress du réticulum endoplasmique/génétique , Mutation ponctuelle/génétique , Fibrose pulmonaire/génétique , Protéine C associée au surfactant pulmonaire/génétique , Transporteurs ABC/génétique , Adolescent , Substitution d'acide aminé/génétique , Apoptose/génétique , Biopsie , Santé de la famille , Femelle , Cellules HEK293 , Humains , Mâle , Pedigree , Fibrose pulmonaire/ethnologie , Fibrose pulmonaire/anatomopathologie
7.
Lett Appl Microbiol ; 53(1): 35-43, 2011 Jul.
Article de Anglais | MEDLINE | ID: mdl-21554343

RÉSUMÉ

AIMS: Oral administration of probiotics has been known to improve inflammatory responses against infectious diseases. Here, we describe the inhibitory effect of oral intake of heat-killed Lactobacillus pentosus strain b240 (b240) on pneumococcal pneumonia in a murine experimental model. METHOD AND RESULTS: The mice treated with oral b240 for 21 days before Streptococcus pneumoniae infection exhibited prolonged survival time and less body weight loss, compared with saline-treated control mice. Mild pneumonia with significantly reduced secretion of inflammatory cytokines/chemokines according to related mitogen-activated protein kinase signalling molecules (phosphorylated c-Jun N-terminal kinase) was found in b240-treated mice, whereas severe pneumonia with hypercytokinemia was evident in control mice. Prominent reduction in the number of pneumococci and elevated expression of Toll-like receptor 2 and 4 in the lung tissues was concomitantly noted in b240-treated mice. CONCLUSIONS: These findings indicate that b240 has inhibitory effects on pneumococcal pneumonia induced by Strep. pneumoniae infection and improves inflammatory tissue responses, resulting in reduced damages to the respiratory tissues. SIGNIFICANCE AND IMPACT OF THE STUDY: These results demonstrate that oral administration of b240 might protect host animals from Strep. pneumoniae infection by augmentation of innate immune response.


Sujet(s)
Lactobacillus , Pneumonie à pneumocoques/immunologie , Probiotiques/administration et posologie , Streptococcus pneumoniae , Animaux , Cytokines/immunologie , Cytokines/métabolisme , Lactobacillus/classification , Poumon/immunologie , Poumon/microbiologie , Système de signalisation des MAP kinases , Mâle , Souris , Souris de lignée BALB C , Pneumonie à pneumocoques/microbiologie , Organismes exempts d'organismes pathogènes spécifiques , Récepteurs de type Toll/immunologie
8.
Clin Nephrol ; 75(2): 158-64, 2011 Feb.
Article de Anglais | MEDLINE | ID: mdl-21255546

RÉSUMÉ

We report the case of a 31-year-old male with enlarged kidneys and glomerulocystic kidney disease (GCKD). The patient had no family history of renal disease or other diseases. On initial presentation he complained of poor eyesight, and hypertensive retinopathy and elevated serum creatinine (5.0 mg/dl) were found at that time. Renal biopsy showed cystic dilatation of Bowman's capsule and atrophy of the glomerular tuft. Thus, an adult case of sporadic GCKD was diagnosed. Based on previous reports, kidney size in patients with adult type GCKD varies from small to large. Our patient's kidneys are the largest ever reported (right kidney was 22 cm×10 cm, left kidney was 19 cm×10 cm). A review of the literature dealing with sporadic adult GCKD suggested that it is difficult to diagnose this disease early in its course.


Sujet(s)
Maladies kystiques rénales/diagnostic , Rein/anatomopathologie , Adulte , Biopsie , Capsule de Bowman/anatomopathologie , Humains , Rein/imagerie diagnostique , Maladies kystiques rénales/thérapie , Glomérule rénal/anatomopathologie , Imagerie par résonance magnétique , Mâle , Taille d'organe , Valeur prédictive des tests , Dialyse rénale , Tomodensitométrie , Échographie
9.
Article de Anglais | MEDLINE | ID: mdl-22255735

RÉSUMÉ

Brain-machine interfaces (BMI) are expected as new man-machine interfaces. Non-invasive BMI have the potential to improve the quality of life of many disabled individuals with safer operation. The non-invasive BMI using the functional functional near-infrared spectroscopy (fNIRS) with the electroencephalogram (EEG) has potential applicability beyond the restoration of lost movement and rehabilitation in paraplegics and would enable normal individuals to have direct brain control of external devices in their daily lives. To shift stage of the non-invasive BMI from laboratory to clinical, the key factor is to develop high-accuracy signal decoding technology and highly restrictive of the measurement area. In this article, we present the development of a high-accuracy brain activity measurement system by combining fNIRS and EEG. The new fNIRS had high performances with high spatial resolution using double density technique and a large number of measurement channels to cover a whole human brain.


Sujet(s)
Encéphale/anatomopathologie , Électroencéphalographie/méthodes , Spectroscopie proche infrarouge/méthodes , Absorption , Conception d'appareillage , Hémoglobines/métabolisme , Humains , Imagerie tridimensionnelle/méthodes , Imagerie par résonance magnétique/méthodes , Systèmes homme-machine , Oxygène/composition chimique , Fantômes en imagerie , Qualité de vie , Robotique , Dispositifs d'assistance au mouvement , Interface utilisateur
10.
Clin Exp Allergy ; 40(10): 1507-15, 2010 Oct.
Article de Anglais | MEDLINE | ID: mdl-20412133

RÉSUMÉ

BACKGROUND: The role in allergic asthma development of the immune response against fungi with concomitant exposure to other common aeroallergens has yet to be determined. In particular, there is little understanding of how inhaled fungi affect the host response to mite allergens. OBJECTIVE: To characterize the in vitro and in vivo effects of concurrent exposure of Aspergillus fumigatus (Af) and Dermatophagoides farinae (Derf) on dendritic cells (DCs) in the development of allergic asthma. METHODS: Murine bone marrow-derived DCs were pulsed with Derf and/or live or heat-inactivated Af. Cytokine production and the expression of pathogen recognition receptors (PRRs) were determined in vitro. Subsequently, these DCs were inoculated into the airway of naïve mice to assess the development of allergic airway inflammation in vivo. The effect of antibodies against PRRs was also evaluated. RESULTS: Live Af significantly enhanced IL-10 production and the expression of Toll-like receptor (TLR) 2 and Dectin-1 in Derf-pulsed DCs. Live Af infection significantly attenuated Derf-pulsed DC-induced allergic airway inflammation in vivo. Antibodies against either TLR2 or Dectin-1 significantly reversed the inhibitory effects of live Af in the development of Derf-pulsed DC-induced allergic airway inflammation. CONCLUSION: Concurrent exposure of DCs to fungal antigens has profound influences on the subsequent mite allergen-induced allergic airway inflammation. Live Af could regulate the functions of airway DCs in the development of mite allergen-induced allergic airway inflammation via regulation of their PRRs. Our results suggest that concurrent exposure to pathogens such as fungi and mite allergens has profound influences on the subsequent allergen-induced allergic airway inflammation. Furthermore, modulating PRR signalling could provide a therapeutic regimen for the development of asthma.


Sujet(s)
Aspergillus fumigatus/immunologie , Asthme/immunologie , Asthme/microbiologie , Cellules dendritiques/immunologie , Animaux , Antigènes de Dermatophagoides/immunologie , Antigènes fongiques/immunologie , Cytokines/biosynthèse , Cytokines/immunologie , Femelle , Hypersensibilité/immunologie , Hypersensibilité/microbiologie , Lectines de type C , Protéines membranaires/biosynthèse , Protéines membranaires/immunologie , Souris , Souris de lignée BALB C , Mites (acariens)/immunologie , Protéines de tissu nerveux/biosynthèse , Protéines de tissu nerveux/immunologie , Récepteur de type Toll-2/biosynthèse , Récepteur de type Toll-2/immunologie
11.
J Phys Condens Matter ; 22(9): 095601, 2010 Mar 10.
Article de Anglais | MEDLINE | ID: mdl-21389420

RÉSUMÉ

We studied the electronic structure of the band-filling CaVO(3) and LaVO(3) compounds. The experimental techniques were photoemission (PES) and x-ray absorption (XAS) spectroscopy. The experimental results were analyzed using an extended cluster model. The ground states of CaVO(3) and LaVO(3) are highly covalent and contain a considerable 3d(n + 1)L contribution. The CaVO(3) compound is in the charge transfer regime (Δ < U), whereas the LaVO(3) material is in the intermediate regime (Δ âˆ¼ U). The spectral weight distributions reveal that CaVO(3) is a coherent metal and that LaVO(3) is a p-d insulator. The photoemission of CaVO(3) shows the coherent peak (3d(1)C) and the incoherent feature (3d(1)L). The spectrum of insulating LaVO(3) presents only the incoherent structure (3d(2)L), whereas the coherent peak is replaced by the Mott-Hubbard screening (3d(2)D). This transfer of spectral weight is responsible for the opening of the experimental bandgap. The incoherent feature contains a considerable O 2p character and cannot be attributed to the lower Hubbard band. Further, the relative V 3d-O 2p cross section helps to explain the photon energy dependence of the PES spectra. The addition spectra of both CaVO(3) and LaVO(3) are dominated by the 3d(n + 1) final state configuration. The distribution of spectral weight is mainly dictated by intra-atomic exchange and crystal field splittings. The coherent contribution is less important than in photoemission, and is greatly diminished in the O 1s x-ray absorption spectra.

12.
Sex Dev ; 4(1-2): 73-87, 2010.
Article de Anglais | MEDLINE | ID: mdl-19940440

RÉSUMÉ

Sex determination in the American alligator depends on the incubation temperature experienced during a thermo-sensitive period (TSP), although sex determination can be 'reversed' by embryonic exposure to an estrogenic compound. Thus, temperature and estrogenic signals play essential roles during temperature-dependent sex determination (TSD). The genetic basis for TSD is poorly understood, although previous studies observed that many of the genes associated with genetic sex determination (GSD) are expressed in species with TSD. Heat shock proteins (HSPs), good candidates because of their temperature-sensitive expression, have not been examined in regard to TSD but HSPs have the ability to modify steroid receptor function. A number of HSP cDNAs (HSP27, DNAJ, HSP40, HSP47, HSP60, HSP70A, HSP70B, HSP70C, HSP75, HSP90alpha, HSP90beta, and HSP108) as well as cold-inducible RNA binding protein (CIRBP) and HSP-binding protein (HSPBP) were cloned, and expression of their mRNA in the gonadal-adrenal-mesonephros complex (GAM) was investigated. Embryonic and neonatal GAMs exhibited mRNA for all of the HSPs examined during and after the TSP. One-month-old GAMs were separated into 3 portions (gonad, adrenal gland, and mesonephros), and sexual dimorphism in the mRNA expression of gonadal HSP27 (male > female), gonadal HSP70A (male < female), and adrenal HSP90 alpha (male > female) was observed. These findings provide new insights on TSD and suggest that further studies examining the role of HSPs during gonadal development are needed.


Sujet(s)
Alligators et crocodiles/génétique , Température du corps/physiologie , Protéines du choc thermique/métabolisme , Processus de détermination du sexe , Glandes surrénales/cytologie , Glandes surrénales/croissance et développement , Glandes surrénales/métabolisme , Amériques , Séquence d'acides aminés , Animaux , Clonage moléculaire , Embryon non mammalien/métabolisme , Femelle , Régulation de l'expression des gènes au cours du développement , Gonades/cytologie , Gonades/croissance et développement , Gonades/métabolisme , Protéines du choc thermique HSP70/composition chimique , Protéines du choc thermique HSP70/génétique , Protéines du choc thermique HSP70/métabolisme , Protéines du choc thermique HSP90/composition chimique , Protéines du choc thermique HSP90/génétique , Protéines du choc thermique HSP90/métabolisme , Protéines du choc thermique/génétique , Mâle , Mésonéphros/cytologie , Mésonéphros/croissance et développement , Mésonéphros/métabolisme , Données de séquences moléculaires , ARN messager/génétique , ARN messager/métabolisme , RT-PCR , Alignement de séquences , Similitude de séquences d'acides aminés
13.
Endoscopy ; 41(8): 679-83, 2009 Aug.
Article de Anglais | MEDLINE | ID: mdl-19670135

RÉSUMÉ

BACKGROUND AND STUDY AIMS: Endoscopic submucosal dissection (ESD) permits removal of colorectal epithelial neoplasms en bloc, but a substantial risk of procedure-related perforation has been reported. We sought to unravel the clinicopathological factors associated with the clinical outcomes of ESD for colorectal epithelial neoplasms in a large series. PATIENTS AND METHODS: ESD was done in 278 patients with 292 colorectal tumors that fulfilled the inclusion criteria. The criteria for ESD were: lesion greater than 20 mm in size, lesion with fibrotic scarring, locally residual colorectal lesion, or invasive carcinoma with slight submucosal penetration. Resection was assessed as en bloc or piecemeal, complete (en bloc with tumor-free lateral and basal margins) or incomplete. Complications including perforation and bleeding were assessed, and factors related to each were analyzed using logistic regression. Patients underwent multiple follow-up endoscopic examinations (mean 4.6; median 4; range 2 - 9; total number 1010). RESULTS: En bloc resection was achieved in 90.1 % of lesions (263/292) and resection was deemed to be complete in 233 (79.8 %). Right-side colonic location and the finding of fibrosis were the significant contributors to incomplete resection. Perforation was seen in 24 cases (8.2 %), and was associated with large tumor size and the presence of fibrosis. When the contributive factors for each were combined, the risks of incomplete resection and perforation were substantially increased. CONCLUSION: The present study provides useful information for predicting risks for incomplete resection and complication in colorectal ESD.


Sujet(s)
Tumeurs colorectales/chirurgie , Oesophagoscopie/effets indésirables , Muqueuse/chirurgie , Tumeurs épithéliales épidermoïdes et glandulaires/chirurgie , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Loi du khi-deux , Tumeurs colorectales/anatomopathologie , Dissection , Femelle , Fibrose , Hémorragie gastro-intestinale/étiologie , Humains , Perforation intestinale/étiologie , Modèles logistiques , Mâle , Adulte d'âge moyen , Muqueuse/anatomopathologie , Invasion tumorale , Tumeurs épithéliales épidermoïdes et glandulaires/anatomopathologie , Facteurs de risque , Statistique non paramétrique , Résultat thérapeutique
14.
J Infect Chemother ; 15(3): 156-67, 2009 Jun.
Article de Anglais | MEDLINE | ID: mdl-19554400

RÉSUMÉ

For the purpose of a nationwide surveillance of the antimicrobial susceptibility of bacterial respiratory pathogens in patients in Japan, the Japanese Society of Chemotherapy conducted their second year survey, during the period from January to August, 2007. A total of 1178 strains were collected from clinical specimens obtained from adult patients with well-diagnosed respiratory tract infections. Susceptibility testing was evaluable for 1108 strains (226 Staphylococcus aureus, 257 Streptococcus pneumoniae, 6 Streptococcus pyogenes, 206 Haemophilus influenzae, 120 Moraxella catarrhalis, 122 Klebsiella pneumoniae, and 171 Pseudomonas aeruginosa). A total of 44 antibacterial agents, including 26 beta-lactams (four penicillins, three penicillins in combination with beta-lactamase inhibitors, four oral cephems, eight parenteral cephems, one monobactam, five carbapenems, and one penem), three aminoglycosides, four macrolides (including ketolide), one lincosamide, one tetracycline, two glycopeptides, six fluoroquinolones, and one oxazolidinone were used for the study. Analysis was conducted at the central reference laboratory according to the method recommended by the Clinical and Laboratory Standards Institute (CLSI). The incidence of methicillinresistant Staphylococcus aureus (MRSA) was high, at 59.7%, and the incidences of penicillin-intermediateresistant and -resistant Streptococcus pneumoniae (PISP and PRSP) were 30.4% and 5.1%, respectively. Among Haemophilus influenzae strains, 19.9% of them were found to be beta-lactamase-non-producing ampicillin (ABPC)-intermediately-resistant (BLNAI), 29.1% to be beta-lactamasenon-producing ABPC-resistant (BLNAR), and 6.7% to be beta-lactamase-producing ABPC-resistant (BLPAR) strains. Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae was not isolated. Two isolates (1.2%) of Pseudomonas aeruginosa were found to be metallo-beta-lactamase-producing strains, including one (0.6%) suspected multidrug-resistant strain showing resistance to imipenem, amikacin, and ciprofloxacin. These data will be a useful reference for future periodic surveillance studies and for investigations to control resistant infections as well. Continued surveillance is required to prevent the further spread of these antimicrobial resistances.


Sujet(s)
Antibactériens/pharmacologie , Infections bactériennes/microbiologie , Résistance bactérienne aux médicaments , Bactéries à Gram négatif/effets des médicaments et des substances chimiques , Bactéries à Gram positif/effets des médicaments et des substances chimiques , Infections de l'appareil respiratoire/microbiologie , Adulte , Infections bactériennes/épidémiologie , Bactéries à Gram négatif/isolement et purification , Bactéries à Gram positif/isolement et purification , Humains , Japon/épidémiologie , Tests de sensibilité microbienne , Infections de l'appareil respiratoire/épidémiologie
16.
Scand J Rheumatol ; 38(4): 263-7, 2009.
Article de Anglais | MEDLINE | ID: mdl-19444719

RÉSUMÉ

OBJECTIVE: To determine the association of distinct clinical subsets with myositis-specific autoantibodies (MSAs) towards anti-155/140-kDa polypeptides [anti-155/140 antibodies (Abs)], anti-140-kDa polypeptides (anti-140 Abs), and anti-aminoacyl tRNA synthetases (ARS Abs) in Japanese patients with dermatomyositis (DM). METHODS: We compared the clinical features and short-term prognoses of 30 DM patients whose serological status included these MSAs. The MSAs were determined by immunoprecipitation. RESULTS: Anti-155/140 Abs (n = 5), anti-140 Abs (n = 8), and anti-ARS Abs (n = 7) did not overlap each other. All of the anti-155/140 Ab-positive patients (n = 5) were complicated by malignancies, as were all of the anti-140 Ab-positive patients (n = 8), who showed rapidly progressive interstitial lung disease (ILD). The survival rate at 6 months from the diagnosis of DM was significantly lower in the anti-140 Ab-positive patients than in the other patients. CONCLUSION: This is the first study to report, in a single cohort of DM patients, that distinct clinical subsets are distributed in an anti-155/140 Ab-positive group, an anti-140 Ab-positive group, or an anti-ARS Ab-positive group. Our data also confirm previous evidence that anti-155/140 Abs are involved in malignancies and that anti-140 Abs are involved in rapidly progressive ILD.


Sujet(s)
Amino acyl-tRNA synthetases/immunologie , Autoanticorps/immunologie , Dermatomyosite/diagnostic , Dermatomyosite/immunologie , ARN de transfert/immunologie , Adulte , Sujet âgé , Études de cohortes , Études transversales , Femelle , Humains , Immunoprécipitation , Japon , Estimation de Kaplan-Meier , Mâle , Adulte d'âge moyen , Peptides/immunologie , Probabilité , Statistique non paramétrique
17.
Int J Clin Pract ; 63(2): 269-74, 2009 Feb.
Article de Anglais | MEDLINE | ID: mdl-19196365

RÉSUMÉ

BACKGROUND: The prevalence of chronic obstructive pulmonary disease (COPD) continues to increase all over the world. Nonetheless, COPD is often misdiagnosed in general clinics because of insufficient use of spirometry. OBJECTIVES: To estimate the prevalence of COPD in general clinics in Japan, we performed spirometry to screen patients who consulted general clinics. METHODS: Patients 40 years of age and older who consulted clinics in Nagasaki Prefecture, Japan, for non-respiratory diseases and who met certain inclusion criteria had their airflow limitation measured by spirometry. We defined COPD as forced expiratory volume in the first second (FEV(1)) over forced vital capacity (FVC) (FEV(1)/FVC) of < 70% in patients without active pulmonary disease, including physician-diagnosed asthma. RESULTS: Of the 1424 patients included in the study, 193 (13.6%) showed airflow limitation. Airflow limitation was significantly related to older age, male gender and cumulative pack-years. FEV(1)/FVC in patients with hypertension and chronic hepatitis were significantly lower than in patients without these diseases when adjusted for age, gender and pack-years. CONCLUSIONS: We showed that there are potentially a number of cases with COPD that are undiagnosed by general physicians in Japan. Measuring airflow limitation by spirometry in smokers with coexisting diseases, such as hypertension and chronic hepatitis, may be very beneficial because COPD is thought to be a systemic disease. The distribution of spirometers to general clinics is definitely needed to detect undiagnosed COPD.


Sujet(s)
Broncho-pneumopathie chronique obstructive/épidémiologie , Adulte , Sujet âgé , Soins ambulatoires/statistiques et données numériques , Volume expiratoire maximal par seconde , Humains , Japon/épidémiologie , Mâle , Adulte d'âge moyen , Prévalence , Broncho-pneumopathie chronique obstructive/diagnostic , Broncho-pneumopathie chronique obstructive/physiopathologie , Fumer/épidémiologie , Fumer/physiopathologie , Spirométrie , Capacité vitale
18.
Inflamm Res ; 58(4): 192-7, 2009 Apr.
Article de Anglais | MEDLINE | ID: mdl-19184352

RÉSUMÉ

BACKGROUND: Impaired production/release of defensins, representative endogenous antimicrobial peptides, is associated with the pathogenesis of inflammatory bowel disease (IBD). MATERIAL AND METHODS: Employing in house radioimmunoassay, we examined concentrations of the major forms alpha-defensins, human neutrophil peptides (HNP) 1-3 and human beta-defensin (HBD)-2 in plasma of 55 IBD patients consisting of 29 patients with ulcerative colitis (UC) and 26 with Crohn's disease (CD) and 57 controls. RESULTS: The circulating HNP 1-3, but not HBD-2, levels in IBD patients were significantly higher than those in controls. Plasma HNP 1-3 concentrations in CD patients significantly correlated with Crohn's disease activity index, peripheral white blood cell counts, serum CRP values and TNF-alpha levels. CONCLUSIONS: Elevation of circulating alpha-defensins levels is suggestive of their physiopathological roles in IBD. Plasma HNP 1-3 concentrations may be an indicator for CD activity and their association with CRP and TNF-alpha supports a possible association with the inflammatory process.


Sujet(s)
Maladies inflammatoires intestinales/sang , Défensines-alpha/sang , bêta-Défensines/sang , Adolescent , Adulte , Sujet âgé , Anti-infectieux/sang , Femelle , Humains , Maladies inflammatoires intestinales/anatomopathologie , Maladies inflammatoires intestinales/physiopathologie , Mâle , Adulte d'âge moyen , Indice de gravité de la maladie , Statistiques comme sujet , Jeune adulte
19.
Clin Exp Allergy ; 39(1): 138-46, 2009 Jan.
Article de Anglais | MEDLINE | ID: mdl-18778270

RÉSUMÉ

BACKGROUND: Although it has been suggested that the use of tachykinin receptor antagonists might prove to be an effective treatment for allergic rhinitis (AR), they are not used clinically. Therefore, we decided to examine the effects of tachykinin receptor antagonists on AR symptoms in an appropriate experimental model. OBJECTIVE: To evaluate newly developed tachykinin receptor antagonists in a Japanese cedar pollen-induced AR model and to determine their effect on allergen-induced sneezing, nasal blockage, and nasal hyperresponsiveness (NHR). METHODS: Sensitized guinea-pigs were challenged by forced inhalation of pollen once every week. Sneezing and nasal blockage were observed after pollen challenges. NHR (nasal blockage) to an intranasal application of leukotriene D(4) was assessed 2 days after an antigen challenge. We also evaluated whether intranasal dosing with a tachykinin causes NHR. NK(1) and NK(2) receptor antagonists were administered before an intranasal treatment with antigen or tachykinin. Amounts of tachykinins present in nasal cavity lavage fluid were measured by an enzyme immunoassay. RESULTS: Although an NK(1) and NK(2) receptor dual antagonist showed no effect on pollen-induced sneezing and biphasic nasal blockage, it did completely suppress the development of NHR. Experiments using specific NK(1) or NK(2) receptor antagonists revealed that NK(2) receptor activation was preferentially involved in the development of hyperresponsiveness. Increases in the levels of substance P (SP) and neurokinin A (NKA) in the nasal tissue were noted 20 min-1 h after the challenge. Intranasal instillation of either SP or NKA-induced NHR, which was almost completely inhibited by NK(2) receptor antagonists and partially inhibited by NK(1) receptor antagonists. CONCLUSIONS: SP and NKA, which are released early after the challenge, mediate the development of NHR by preferentially activating NK(2) receptors. Therefore, NK(2) receptor antagonists might prove to be effective treatment of AR.


Sujet(s)
Allergènes/immunologie , Modèles animaux de maladie humaine , Pollen/immunologie , Rhinite allergique saisonnière/physiopathologie , Tachykinines/métabolisme , Animaux , Cochons d'Inde , Humains , Liquide de lavage nasal/composition chimique , Obstruction nasale , Tests de provocation nasale , Neurokinine A/métabolisme , Nez , Récepteur neurokinine 2/antagonistes et inhibiteurs , Récepteur neurokinine 2/usage thérapeutique , Récepteur tachykinine/antagonistes et inhibiteurs , Récepteur tachykinine/usage thérapeutique , Rhinite allergique saisonnière/traitement médicamenteux , Rhinite allergique saisonnière/immunologie , Rhinite allergique saisonnière/métabolisme , Éternuement , Substance P/métabolisme
20.
Gut ; 58(3): 331-6, 2009 Mar.
Article de Anglais | MEDLINE | ID: mdl-19001058

RÉSUMÉ

OBJECTIVE: Endoscopic submucosal dissection (ESD) has the advantage over conventional endoscopic mucosa resection, permitting removal of early gastric cancer (EGC) en bloc, but long-term clinical outcomes remain unknown. A follow-up study on tumour recurrence and survival after ESD was conducted. METHOD: ESD was performed for patients with EGC that fulfilled the expanded criteria: mucosal cancer without ulcer findings irrespective of tumour size; mucosal cancer with ulcer findings

Sujet(s)
Adénocarcinome/chirurgie , Endoscopie/méthodes , Muqueuse gastrique/chirurgie , Récidive tumorale locale/chirurgie , Tumeurs de l'estomac/chirurgie , Adénocarcinome/anatomopathologie , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Dissection , Dépistage précoce du cancer , Études de faisabilité , Femelle , Études de suivi , Muqueuse gastrique/anatomopathologie , Humains , Métastase lymphatique , Mâle , Adulte d'âge moyen , Récidive tumorale locale/anatomopathologie , Stadification tumorale , Tumeurs de l'estomac/anatomopathologie , Résultat thérapeutique
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...